INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
130.39 USD
+13.1 (+11.17%)
133.65 USD
+3.26 (+2.5%)
INSP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP is valued quite expensive, but it does show an excellent growth. These ratings could make INSP a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
In the past year INSP had a positive cash flow from operations.
INSP had negative earnings in 4 of the past 5 years.
In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
INSP's Return On Assets of 5.52% is amongst the best of the industry. INSP outperforms 82.45% of its industry peers.
INSP's Return On Equity of 6.69% is amongst the best of the industry. INSP outperforms 80.85% of its industry peers.
INSP's Return On Invested Capital of 4.82% is fine compared to the rest of the industry. INSP outperforms 76.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INSP has a Profit Margin of 5.05%. This is in the better half of the industry: INSP outperforms 77.13% of its industry peers.
INSP's Operating Margin of 4.16% is fine compared to the rest of the industry. INSP outperforms 69.15% of its industry peers.
INSP has a better Gross Margin (84.92%) than 94.15% of its industry peers.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INSP is destroying value.
Compared to 1 year ago, INSP has more shares outstanding
The number of shares outstanding for INSP has been increased compared to 5 years ago.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
INSP has an Altman-Z score of 17.84. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
INSP's Altman-Z score of 17.84 is amongst the best of the industry. INSP outperforms 94.68% of its industry peers.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 17.84 |
ROIC/WACC0.56
WACC8.68%
2.3 Liquidity
INSP has a Current Ratio of 5.29. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP has a Current ratio of 5.29. This is amongst the best in the industry. INSP outperforms 80.85% of its industry peers.
A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.01, INSP is in the better half of the industry, outperforming 76.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 90.65% over the past year.
The Revenue has grown by 16.81% in the past year. This is quite good.
INSP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.78% yearly.
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
Based on estimates for the next years, INSP will show a very strong growth in Earnings Per Share. The EPS will grow by 28.29% on average per year.
INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.84% yearly.
EPS Next Y-70.2%
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
EPS Next 5Y28.29%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y13.96%
Revenue Next 5Y12.84%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 63.92, which means the current valuation is very expensive for INSP.
INSP's Price/Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 67.55% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.98, INSP is valued quite expensively.
INSP is valuated quite expensively with a Price/Forward Earnings ratio of 80.93.
65.96% of the companies in the same industry are more expensive than INSP, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.79, INSP is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.92 | ||
| Fwd PE | 80.93 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INSP is valued a bit cheaper than 64.89% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, INSP is valued a bit cheaper than 77.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.02 | ||
| EV/EBITDA | 67.35 |
4.3 Compensation for Growth
INSP's earnings are expected to grow with 16.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
5. Dividend
5.1 Amount
INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
130.39
+13.1 (+11.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.56%
Inst Owner Change-6.75%
Ins Owners0.82%
Ins Owner Change0.2%
Market Cap3.86B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts73.85
Price Target113.99 (-12.58%)
Short Float %12.31%
Short Ratio2.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-18.42%
PT rev (3m)-24.61%
EPS NQ rev (1m)1.08%
EPS NQ rev (3m)-31.36%
EPS NY rev (1m)1.28%
EPS NY rev (3m)0.91%
Revenue NQ rev (1m)-0.71%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.92 | ||
| Fwd PE | 80.93 | ||
| P/S | 4.37 | ||
| P/FCF | 39.02 | ||
| P/OCF | 28.84 | ||
| P/B | 5.79 | ||
| P/tB | 5.79 | ||
| EV/EBITDA | 67.35 |
EPS(TTM)2.04
EY1.56%
EPS(NY)1.61
Fwd EY1.24%
FCF(TTM)3.34
FCFY2.56%
OCF(TTM)4.52
OCFY3.47%
SpS29.85
BVpS22.54
TBVpS22.54
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 17.84 |
F-Score8
WACC8.68%
ROIC/WACC0.56
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-70.2%
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
EPS Next 5Y28.29%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y13.96%
Revenue Next 5Y12.84%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year586.15%
EBIT Next 3Y128.27%
EBIT Next 5Y79.93%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
Can you provide the ChartMill fundamental rating for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
What is the valuation status of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a valuation rating of 3 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Overvalued.
Can you provide the profitability details for INSPIRE MEDICAL SYSTEMS INC?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
Can you provide the financial health for INSP stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.
What is the expected EPS growth for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -70.2% in the next year.